Talmont F - Search Results

1

Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts.

Talmont F, Mitri E, Dozier C, Besson A, Cuvillier O, Hatzoglou A. Talmont F, et al. Cancers (Basel). 2022 Mar 25;14(7):1661. doi: 10.3390/cancers14071661. Cancers (Basel). 2022. PMID: 35406433 Free PMC article.

2

Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors.

Talmont F, Moulédous L, Baranger M, Gomez-Brouchet A, Zajac JM, Deffaud C, Cuvillier O, Hatzoglou A. Talmont F, et al. PLoS One. 2019 Mar 7;14(3):e0213203. doi: 10.1371/journal.pone.0213203. eCollection 2019. PLoS One. 2019. PMID: 30845158 Free PMC article.

3

[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors].

Talmont F, Hatzoglou A, Cuvillier O. Talmont F, et al. Med Sci (Paris). 2020 Mar;36(3):243-252. doi: 10.1051/medsci/2020026. Epub 2020 Mar 31. Med Sci (Paris). 2020. PMID: 32228843 Free article. Review. French.

4

Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters.

Gomez-Brouchet A, Illac C, Ledoux A, Fortin PY, de Barros S, Vabre C, Despas F, Peries S, Casaroli C, Bouvier C, Aubert S, de Pinieux G, Larousserie F, Galmiche L, Talmont F, Pitson S, Maddelein ML, Cuvillier O. Gomez-Brouchet A, et al. Among authors: talmont f. Cancers (Basel). 2022 Jan 19;14(3):499. doi: 10.3390/cancers14030499. Cancers (Basel). 2022. PMID: 35158767 Free PMC article.

5

Pharmacological Characterization of [¹⁸F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model.

Beaurain M, Talmont F, Pierre D, Péran P, Boucher S, Hitzel A, Rols MP, Cuvillier O, Payoux P, Salabert AS. Beaurain M, et al. Among authors: talmont f. Mol Imaging Biol. 2023 Aug;25(4):692-703. doi: 10.1007/s11307-023-01811-y. Epub 2023 Mar 21. Mol Imaging Biol. 2023. PMID: 36944798 Free PMC article.

6

Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Talmont F, Moulédous L. Talmont F, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 May;387(5):427-31. doi: 10.1007/s00210-014-0957-5. Epub 2014 Jan 24. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 24458374

7

Pharmacological characterization of the mouse NPFF2 receptor.

Talmont F, Moulédous L, Piedra-Garcia L, Schmitt M, Bihel F, Bourguignon JJ, Zajac JM, Mollereau C. Talmont F, et al. Peptides. 2010 Feb;31(2):215-20. doi: 10.1016/j.peptides.2009.11.020. Epub 2009 Nov 26. Peptides. 2010. PMID: 19944730

8

Agonist binding of human mu opioid receptors expressed in the yeast Pichia pastoris: Effect of cholesterol complementation.

Talmont F, Lebrun C, Zajac JM. Talmont F, et al. Neurochem Int. 2020 Jan;132:104588. doi: 10.1016/j.neuint.2019.104588. Epub 2019 Nov 6. Neurochem Int. 2020. PMID: 31704091

9

Pharmacological insight into the activation of the human neuropeptide FF2 receptor.

Talmont F, Veneziano R, Dietrich G, Moulédous L, Mollereau C, Zajac JM. Talmont F, et al. Peptides. 2020 Dec;134:170406. doi: 10.1016/j.peptides.2020.170406. Epub 2020 Sep 10. Peptides. 2020. PMID: 32920044

10

Denatured G-protein coupled receptors as immunogens to generate highly specific antibodies.

Talmont F, Moulédous L, Boué J, Mollereau C, Dietrich G. Talmont F, et al. PLoS One. 2012;7(9):e46348. doi: 10.1371/journal.pone.0046348. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23029489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page